Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA clears Fortovase

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Apomorphine designated orphan drug

Nov. 7, 1997

Gensia Sicor terminates collaboration with Atrix

Nov. 7, 1997

Patient enrollment complete for phase II trial of memantine

Nov. 6, 1997

FDA approves generic formulation of oxycodone/acetaminophen

Nov. 6, 1997

Inhibition of human pancreatic cancer invasion and metastasis by serine protease inhibitor

Nov. 3, 1997

Clinical data reported for Actiq

Nov. 3, 1997

FDA clears generic cimetidine

Oct. 29, 1997

Pravachol now available in Canada for preventing a first heart attack

Oct. 29, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...